Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSENS.L Regulatory News (SENS)

  • There is currently no data for SENS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - Sensyne Health Plc

11 Apr 2022 12:00

RNS Number : 9604H
Peel Hunt LLP
11 April 2022
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Peel Hunt LLP

(b) Name of offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Sensyne Health Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Sensyne Health Plc

(d) Date dealing undertaken:

08 April 2022

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

 

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary Shares

Buy

17,343,328

 

3.38 GBx

1.25 GBx

Ordinary Shares

Sell

21,101,891

 

3.50 GBx

1.18 GBx

 

 (b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

 

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

Date of disclosure:

11 April 2022

 

Contact name:

Alexandra Forner

Telephone number:

0207 847 4740

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERUASKRURUSARR
Date   Source Headline
22nd Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
21st Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
18th Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
17th Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
14th Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
11th Feb 20225:03 pmRNSResults of General Meeting
11th Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
11th Feb 202210:08 amRNSForm 8.5 (EPT/RI)
11th Feb 20228:12 amRNSForm 8.3 - Sensyne Health Plc
10th Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
9th Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
8th Feb 20225:08 pmRNSForm 8.3 - Sensyne Health Plc
8th Feb 20223:14 pmRNSForm 8.3 - Sensyne Health PLC
8th Feb 20221:02 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
8th Feb 20229:34 amRNSUpdate on General Meeting
7th Feb 20221:17 pmBUSForm 8.3 - Sensyne Health Ltd
7th Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
4th Feb 20222:25 pmRNSForm 8.5 (EPT/NON-RI) - Sensyne Health Plc
4th Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
3rd Feb 20224:49 pmRNSForm 8.5 (EPT/RI)-Sensyne Health plc Amend
3rd Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
2nd Feb 20222:24 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
2nd Feb 20228:51 amRNSForm 8.5 (EPT/RI)
1st Feb 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
1st Feb 20228:53 amRNSForm 8.5 (EPT/RI)
31st Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
31st Jan 20228:46 amRNSForm 8.5 (EPT/RI)
31st Jan 20227:02 amRNSSensyne Health Interim Results
28th Jan 20225:07 pmRNSForm 8.3 - Sensyne Health Plc
28th Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
28th Jan 20228:30 amRNSForm 8.5 (EPT/RI)
27th Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
27th Jan 20228:43 amRNSForm 8.5 (EPT/RI)
26th Jan 20226:27 pmRNSPublication of Circular, Notice of General Meeting
26th Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
26th Jan 202211:06 amRNSSecond Price Monitoring Extn
26th Jan 202211:00 amRNSPrice Monitoring Extension
26th Jan 20227:00 amRNSCompletion of financing, notice of General Meeting
25th Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
25th Jan 20229:26 amRNSForm 8.3 - Sensyne Health Plc
24th Jan 20221:39 pmGNWInvesco Ltd.: Form 8.3 - Sensyne Health Plc.
24th Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
24th Jan 20228:58 amRNSForm 8.5 (EPT/RI)
21st Jan 20221:38 pmGNWInvesco Ltd.: Form 8.3 - Sensyne Health Plc.
21st Jan 202212:00 pmRNSPeel Hunt LLP – FORM 8.5 (EPT/RI)
21st Jan 20228:59 amRNSForm 8.5 (EPT/RI)
21st Jan 20228:23 amRNSForm 8.3 - Sensyne Health Plc
20th Jan 20223:00 pmBUSForm 8.3 - SENS LN
20th Jan 20222:47 pmBUSForm 8.3 - SENS LN - Amendment
20th Jan 20221:13 pmGNWInvesco Ltd.: Form 8.3 - Sensyne Health Plc.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.